δ-Opioid Receptor as a Molecular Target for Increasing Cardiac Resistance to Reperfusion in Drug Development

Area of Science:

• Cardiovascular Physiology
• Molecular Cardiology
• Pharmacology

Background:

• Reperfusion injury remains a significant challenge in cardiovascular medicine.
• The role of opioid receptors in cardiac protection is an area of ongoing research.
• Peripheral opioid receptors, particularly δ2-opioid receptors (δ2-OR), have been implicated in modulating cardiac function.

Purpose of the Study:

• To investigate the role of peripheral δ2-opioid receptors (δ2-OR) in cardiac tolerance to reperfusion.
• To elucidate the signaling pathways and molecular targets involved in the cardioprotective effects of δ2-OR activation.

Main Methods:

• Analysis of published data and original experimental studies.
• Assessment of cardiac tolerance to reperfusion following δ2-OR activation.
• Investigation of protein kinase activation (PKCδ, ERK1/2, PI3K, PKG) and effector pathways (KATP channels, MPT pore).

Main Results:

• Activation of peripheral δ2-opioid receptors (δ2-OR) significantly increases cardiac tolerance to reperfusion.
• δ2-ORs are localized within cardiomyocytes, suggesting a direct role in cardiac protection.
• The infarct-limiting effect of the δ2-OR agonist deltorphin II is mediated by the activation of specific protein kinases.
• Potential downstream effectors include sarcolemmal KATP channels and the mitochondrial permeability transition pore (MPTP).

Conclusions:

• Peripheral δ2-opioid receptor (δ2-OR) activation confers cardioprotection against reperfusion injury.
• The mechanism involves a cascade of protein kinases and likely targets ion channels and mitochondrial pores.
• Endogenous opioids do not appear to regulate cardiac resistance to reperfusion.